Equities

AirSculpt Technologies Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
AIRS:NMQ

AirSculpt Technologies Inc

Actions
Health CareHealth Care Providers
  • Price (USD)1.89
  • Today's Change-0.05 / -2.58%
  • Shares traded428.46k
  • 1 Year change-68.50%
  • Beta2.7711
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

AirSculpt Technologies, Inc., through its wholly owned subsidiaries, is a provider of practice management services to professional associations (PAs) located throughout the United States, Canada, and the United Kingdom. The Company owns and operates non-clinical assets and provides its management services to the PAs through management services agreements (MSAs). It operates through the direct medical procedure services segment. The Company offers fat removal procedures across treatment areas. It also offers fat transfer procedures that use the patient’s own fat cells to enhance the breasts, buttocks, hips, or other areas and do not require silicone or foreign materials to be implanted. Its body contouring procedures include the Power BBL, a Brazilian butt lift procedure, the Up a Cup, a breast enhancement procedure, and the Hip Flip, an hourglass contouring procedure. Its AirSculpt + procedure permanently removes fat and tightens the skin with unparalleled precision and finesse.

  • Revenue in USD (TTM)157.55m
  • Net income in USD-17.98m
  • Incorporated2021
  • Employees389.00
  • Location
    AirSculpt Technologies Inc1111 Lincoln Road, Suite 802MIAMI BEACH 33139United StatesUSA
  • Phone+1 (786) 709-9690
  • Fax+1 (302) 655-5049
  • Websitehttps://airsculpt.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
DocGo Inc368.09m-51.59m72.91m3.40k--0.2695--0.1981-0.5213-0.52133.682.770.8685--2.16108,135.50-14.55---19.45--31.21---16.75------0.0599---1.24--191.50------
Exagen Inc63.60m-19.04m74.33m203.00--4.07--1.17-0.9257-0.92573.140.80581.20--6.21313,295.60-35.78-31.53-44.92-35.8259.8656.16-29.94-53.16---2.010.5911--5.896.6236.19--5.03--
Park Dental Partners Inc240.21m5.14m78.40m--15.24204.165.440.32641.261.2658.710.0939----------------16.20--2.14----9.220.9701--2.81---10.76------
American Well Corp249.33m-95.70m89.38m562.00--0.3766--0.3585-5.95-5.9515.5314.340.656356.974.10443,638.80-24.55-31.34-33.82-36.5353.7942.50-37.41-110.063.35--0.00---1.980.328954.02---63.67--
Biodesix Inc80.17m-39.54m91.09m273.00------1.14-5.36-5.3610.85-0.21650.8375--7.74293,674.00-41.30-51.25-49.31-72.8179.8263.18-49.31-90.86---4.371.04--45.3023.7717.67--19.43--
Airsculpt Technologies Inc157.55m-17.98m118.01m389.00--1.44--0.749-0.2975-0.29752.641.320.7994--50.58405,023.10-9.13-0.9512-10.44-1.0463.9765.87-11.41-1.25---0.67260.4094---7.9534.33-84.22--25.84--
Joint Corp39.73m3.07m129.04m443.0041.975.8026.283.250.2068-0.0672.611.500.5333--11.0489,680.704.122.297.923.3878.8486.627.732.67----0.000.0010.471.3885.73---19.39--
Kindly MD Inc1.98m-90.49m129.80m23.00--0.264--65.55-1.12-1.120.03571.120.0057----86,099.56-25.97---37.58--98.85---4,569.49------0.2983---27.83---123.66------
Zomedica Corp29.45m-84.52m132.29m152.00--1.11--4.49-0.0863-0.08630.03010.12210.17071.729.79193,776.30-49.00-13.58-51.46-14.0068.10---286.96-177.177.02--0.00--8.33---36.07--58.14--
Agilon Health Inc5.89bn-322.90m149.66m1.08k--0.489--0.0254-0.781-0.745514.240.73833.19--5.085,469,862.00-17.51-15.06-62.18-26.410.51497.61-5.49-6.35----0.1025--40.4150.14-28.34--60.26--
Alps Group Inc0.00-2.02m155.19m2.00---------0.5111-0.51110.00-3.060.00-------12.10---23.19-------------7.00---------174.11------
Data as of Feb 13 2026. Currency figures normalised to AirSculpt Technologies Inc's reporting currency: US Dollar USD

Institutional shareholders

26.20%Per cent of shares held by top holders
HolderShares% Held
Thrivent Financial for Lutherans (Investment Portfolio)as of 30 Sep 20255.35m8.56%
SW Investment Management LLCas of 30 Sep 20254.50m7.21%
Balyasny Asset Management LPas of 30 Sep 20251.27m2.03%
The Vanguard Group, Inc.as of 31 Dec 20251.04m1.67%
Renaissance Technologies LLCas of 31 Dec 20251.01m1.61%
BlackRock Fund Advisorsas of 31 Dec 2025895.06k1.43%
National Bank Financial, Inc.as of 30 Sep 2025805.00k1.29%
Wexford Capital LPas of 31 Dec 2025669.94k1.07%
Sculptor Capital LPas of 31 Dec 2025421.60k0.68%
Geode Capital Management LLCas of 31 Dec 2025403.16k0.65%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.